Search the Questions & Answers |
Browse by Category |
|
|
|
<< Return to questions
|
| What are the chances of my daughter spreading the human papillomavirus (HPV) to her sexual partners? #517/10 |
|
My daughter is bisexual and has had sex with both genders. We have just found out she has HPV (human papillomavirus). What are the chances of her spreading to either gender and should she tell all of her sexual partners?
|
Your daughter can spread HPV to males or females.
More than half of the time when an infected woman spreads HPV to an uninfected person, she is completely asymptomatic when the spread of HPV happened.
So your daughter should be using condoms or other barriers consistently whether she is symptomatic at the time or not.
Moreover, she can be infected by males or females with other serotypes of HPV.
For example, there are about 10 HPV types that can cause cervical cancer and only 2 are prevented by the HPV vaccines now available.
Certainly your daughter should have received one of the 2 HPV vaccines.
Has she received an HPV vaccine?
|
Her reply on 5-10: “She had a series of 3 shots for HPV a couple of years before she became sexually active.”
So your daughter is well protected against the 2 most common HPV types that cause cervical cancer. But remember there are close to 100 other serotypes of HPV that are not prevented by Gardasil. Gardasil is the HPV vaccine that your daughter had to have received. Gardasil protects women well against 4 types of HPV. In girls and young women ages 9 to 26, Gardasil protects women well against 2 types of HPV that cause about 75% of cervical cancer cases and 2 more HPV types that cause 90% of genital warts cases. In boys and young men ages 9 to 26, Gardasil helps protect against 90% of genital warts cases.
Gardasil also helps protect girls and young women ages 9 to 26 against 70% of vaginal cancer cases and up to 50% of vulvar cancer cases.
Key Words: bisexual, genders, HPV (human papillomavirus), spread, sexual partners, males, females, infected, asymptomatic, condoms, barriers, serotypes, cervical cancer, prevented, vaccines, Gardasil, vaginal cancer, vulvar cancer, transmission, genital warts
Posted 6-22-2010, Updated 6-25-2010, Updated 7-7-2010
|
Robert A. Hatcher MD, MPH
Professor of Gynecology and Obstetrics
Emory University School of Medicine
Atlanta, GA
---2010-07-7
|
|
|
| | The directors and owners of this website and any publications and information concerning health matters offered here advise a person with a particular problem to consult a primary-care clinician or a specialist in obstetrics, gynecology, or urology (depending on the problem or the contraceptive) as well as the product package insert and other references before diagnosing, managing, or treating the problem. |
| Visitor Comments |
No visitor comments posted.
Post a comment
|
| Related Questions |
|
No related questions were found.
|
| Attachments |
|
No attachments were found.
|
Suggestions, recommendations, questions, comments, data from the literature, interpretation of laboratory tests and other information provided on this site are for informational purposes only and are not intended to be relied upon as advice from or implied to be a substitute for the professional advice of a physician, nurse practitioner, nurse midwife, counselor or other healthcare professional. Always seek the advice of your clinician or other professional for any questions you may have regarding your health, medical condition, method of birth control and other family planning or personal/social issues. Periodic references to costs of birth control methods on this website are estimates only and your actual cost for any specific method of birth control may be more or less than the stated amount. Emory University School of Medicine, Bridging the Gap Foundation, and Bridging the Gap Communications Inc are not responsible for any damage or loss you may incur as a result of your use of or reliance on any material or information provided through this website.
|
|